INTRODUCTION
Lassa fever (LF), a viral haemorrhagic disease, poses a significant public health chall...
BACKGROUND
Killed whole-cell oral cholera vaccines (kOCVs) are a standard prevention and control measure in cholera-endemic areas and during outbreaks and human...
BACKROUND
A large measles outbreak occurred in Yakusu Health Zone, Democratic Republic of the Congo, between Jan 2018 and June 2019. We describe the extent of t...
INTRODUCTION
Various incentive programmes are being used to improve immunisation uptake, despite limited understanding of their effectiveness and potential unin...
BACKGROUND
COVID-19 hit Canada hard and exacerbated health inequities, notably among ethnoracially minoritized populations. By August 2021, some areas in Peel r...
BACKGROUND
The mental health problems during the coronavirus disease 2019 (COVID-19) pandemic may have influenced their decision to receive the COVID-19 vaccine...
Clinical trials in settings with intermittent or non-existent internet and power connectivity, for example ...
In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...
BACKGROUND
Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain u...
BACKGROUND
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...
BACKGROUND
In settings with low pneumococcal conjugate vaccine (PCV) coverage, multi-age cohort mass campaigns could increase population immunity, and fractiona...
BACKGROUND
Tuberculosis vaccine trials using disease as the primary endpoint are large, time consuming, and expensive. An earlier immunological measure of the p...
INTRODUCTION
Migrant populations (asylum seekers, permit holders, refugees, and undocumented migrants) living in South Africa face various individual, social, a...
BACKGROUND
Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas m...
BACKGROUND
Lit...
BACKGROUND
In 2019–2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 n...
BACKRGOUND
The rec...
During the 2018–2020 Ebola virus disease outbreak in Democratic Republic of the Congo, a phase 3 trial of the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine (DRC-EB-001) commenced in Goma, wit...
During the 2018–2020 Ebola virus disease (EVD) outbreak, residents in Goma, Democratic Republic of the Congo, were offered a two-dose prophylactic EVD vaccine. This was the first stud...